This metabolite features a PDE selectivity profile comparable to sildenafil and an in vitro potency for PDE5 somewhere around 50% on the mum or dad drug. Plasma concentrations of the metabolite are approximately 40% of those seen for sildenafil, so which the metabolite accounts for about 20% of sild